China Resources Jiangzhong Pharmaceutical Co.,Ltd (SHA:600750)
China flag China · Delayed Price · Currency is CNY
23.99
-0.93 (-3.73%)
Apr 28, 2026, 3:00 PM CST

SHA:600750 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
838.38709.061,0071,3331,3711,046
Short-Term Investments
-1,233----
Trading Asset Securities
100.0995.110.0150.021,3731,728
Cash & Short-Term Investments
938.472,0381,0171,3832,7442,774
Cash Growth
-45.44%100.28%-26.43%-49.60%-1.07%33.30%
Accounts Receivable
1,174851.49940.69637.79775.45793.54
Other Receivables
24.4826.1116.2964.8743.2648.05
Receivables
1,198877.6956.99702.66818.71841.6
Inventory
408.21454.08460.97487.86386.9377.99
Prepaid Expenses
-----3.88
Other Current Assets
926.7759.1652.2753.08104.6467.24
Total Current Assets
3,4723,4282,4882,6274,0544,064
Property, Plant & Equipment
1,9081,8881,7141,6321,5201,220
Long-Term Investments
129.39930.431,7281,597174.94158.76
Goodwill
52.3752.3741.7441.7441.7441.74
Other Intangible Assets
419.95424.03397.29408.87379.07395.55
Long-Term Deferred Tax Assets
65.0861.0169.2961.1544.4544.9
Long-Term Deferred Charges
5.916.44.064.662.322.77
Other Long-Term Assets
1,10890.6865.9329.0559.0268.97
Total Assets
7,1606,8816,5086,4016,2765,998
Accounts Payable
367.82437.52162.75197.1236.81205.72
Accrued Expenses
70.56850.95983.21856.31813.14692.73
Current Portion of Long-Term Debt
1.11-----
Current Portion of Leases
-1.440.461.251.991.7
Current Income Taxes Payable
120.1744.0857.5848.0919.7712.63
Current Unearned Revenue
284.36192.36288.48293.44358.66299.95
Other Current Liabilities
1,026379.27278.71305.91247.33103.83
Total Current Liabilities
1,8701,9061,7711,7021,6781,317
Long-Term Leases
0.711.170.111.051.182.79
Long-Term Unearned Revenue
81.9183.3790.3349.6167.8573.04
Long-Term Deferred Tax Liabilities
29.8730.8317.8920.1221.5922.72
Other Long-Term Liabilities
156.79156.79156.79---
Total Liabilities
2,1392,1782,0361,7731,7681,415
Common Stock
635.61634.95629.02629.36629.58630
Additional Paid-In Capital
484.92471.29383.02469.65427.35407.82
Retained Earnings
3,2893,0012,8562,8272,8783,008
Treasury Stock
-93.67-84.63-5.72-16.42-31.5-43.28
Total Common Equity
4,3164,0233,8633,9103,9044,003
Minority Interest
704.63680.29608.83718.76604.41579.45
Shareholders' Equity
5,0214,7034,4724,6294,5084,582
Total Liabilities & Equity
7,1606,8816,5086,4016,2765,998
Total Debt
1.822.610.562.33.164.49
Net Cash (Debt)
936.662,0351,0171,3812,7412,769
Net Cash Growth
-45.46%100.13%-26.35%-49.63%-1.02%33.08%
Net Cash Per Share
1.483.211.611.924.354.38
Filing Date Shares Outstanding
626.18637.71636.1984.26625.4623.7
Total Common Shares Outstanding
626.18637.71636.1984.26625.4623.7
Working Capital
1,6021,523716.43924.442,3772,748
Book Value Per Share
6.896.316.073.976.246.42
Tangible Book Value
3,8443,5463,4243,4593,4833,566
Tangible Book Value Per Share
6.145.565.383.515.575.72
Buildings
-1,6421,5571,5151,0831,059
Machinery
-1,2111,1331,030879.7796.66
Construction In Progress
-208.1599.3170.9445.67190.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.